your limit has been reached. plz Donate us to allow your ip full access, Email: sshnevis@outlook.com

Adjusted survival (%) by treatment modality and incident cohort year (year of ESKD onset)

	3 months	12 months	24 months	36 months	60 months
Hemodialysis
2003	91.0	74.8	61.8	51.4	36.6
2005	91.2	75.4	62.7	53.0	38.6
2007	91.6	76.3	64.2	54.6	40.0
2009	91.8	77.5	65.7	56.2	41.6
2011	92.1	78.3	66.8	57.4	42.0
Peritoneal dialysis
2003	96.3	83.9	69.0	57.7	42.9
2005	96.5	85.6	72.2	61.6	45.7
2007	96.9	87.5	74.8	64.5	48.8
2009	97.4	87.8	76.6	66.7	51.5
2011	97.7	89.7	79.0	69.5	52.1
Deceased-donor transplant
2003	95.7	89.9	84.5	79.5	69.2
2005	95.6	89.7	84.9	80.3	71.0
2007	96.7	92.2	88.1	83.7	73.3
2009	96.7	92.0	88.2	84.0	75.1
2011	97.1	93.9	90.4	86.4	76.8
Living-donor transplant
2003	98.1	95.3	91.3	86.9	77.9
2005	98.2	95.2	91.7	88.2	80.3
2007	99.0	97.0	94.3	91.0	83.5
2009	98.9	97.1	94.4	91.1	84.1
2011	98.9	96.3	94.3	91.2	84.1

Adjusted survival probabilities, from day 1, in the ESKD population. Reference population: incident patients with ESKD, 2011. Adjusted for age, sex, race, being Hispanic, and primary diagnosis.

ESKD: end-stage kidney disease.

Reproduced from: United States Renal Data System. 2018 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2018. The data reported here have been supplied by the United States Renal Data System (USRDS). The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy or interpretation of the U.S. government.

Graphic 115217 Version 3.0